Back to top

Tale of the Tape

Zacks Equity Research

Strength Seen in ImmunoCellular Therapeutics (IMUC): Stock Surges 18.4%
January 21, 2014

IMUC ALIOF AFFX

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.


ImmunoCellular Therapeutics, Ltd. (IMUC) was a big mover last session, as the company saw its shares rally over 18% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of 81 cents to $1.04 in the past one-month time frame

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, Friday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

ImmunoCellular Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked biotechnology stocks include Affymetrix Inc. (AFFX - Analyst Report), Actelion Ltd. (ALIOF) and Gentium S.p.A .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
 





Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BOFL HOLDING BOFI 85.03 +4.64%
DIXIE GROUP DXYN 15.24 +3.81%
RAMBUS INC RMBS 12.20 +3.48%
DAIMLER AG DDAIF 93.31 +3.26%
CELL THERAPE CTIC 3.08 +3.01%